Drug companies and investors should be pleased by the latest report commissioned by the Food and Drug Administration -- and it explains why biotech has been so hot during the last few years. The Prescription Drug User Fee Act, or PDUFA, which has been renewed by Congress four times, requires drug companies to pay fees to have their marketing applications reviewed.
Hey, check out all the research scientist jobs. Post your resume today!
